Personal information
Verified email domains
Biography
Currently Head of the Clinical Oncology Department at University Hospital and head of the Faculty of Oncology at Jagiellonian University-Medical College, Krakow, Poland. Graduated from the University of Medical Sciences in Poznan, Poland (2000). Ph.D. in molecular biology (2000). Board-certified in medical oncology (2007). Titular professor of medicine (life-time title granted by President of the Republic of Poland - 2012). Scholarships received: Scholarship of the Ministry of Health 2000; Scholarship for Young Scientists founded by “The Politics/POLITYKA” journal; Scholarships of Foundation for Polish Science; Scholarship of American Society for Clinical Oncology – IDEA. Scientific and clinical training – Dept. of Molecular Biology, Roswell Park Cancer Institute Buffalo, NY (1997) and Dept. of Oncology, Princess Margaret Hospital in Toronto, Canada (2008). President of the Polish Society of Clinical Oncology (2015-2019, 2019-2023). During his medical carrier prof. Wysocki was a promoter of four PhDs and trained dozens of medical oncology residents. He is a lead author of national guidelines for the treatment of genitourinary tumors and coauthor of guidelines in breast cancer. Prof. Wysocki serves as an advisor for the Polish Ministry of Health in the process of the development of a national cancer strategy. For the last six years prof. Wysocki has been selected among the top 100 most prominent and influential physicians in Poland. Over the last decade prof. Wysocki established two early-phase clinical study units in Cracow (Jagiellonian University Hospital) and Szczecin (West Pomeranian Cancer Center). Areas of clinical expertise include systemic treatment of breast, gynecologic, and GU cancers and the development of original metronomic chemotherapy-based therapies (chemo-endocrine, chemo-targeted, and metronomic polychemotherapy) for the treatment of advanced, pretreated cancer patients. Scientific interests include the development and application of Immunopheresis for the treatment of solid tumors and the mitigation of immune-related adverse events. Prof. Wysocki has performed first-in-human studies with therapeutic Immunopheresis and developed clinical study protocols for studies on apheresis-based systemic treatment in various solid tumors. Additionally, prof. Wysocki conducts clinical academic studies on the use of unique metronomic chemotherapy regimens as an optional substitution for targeted agents in the situation of their unavailability in low- and middle-income countries. Over the last 15 years prof. Wysocki acted as principal investigator in >70, phase I-III international clinical studies in oncology conducted in Poland. Prof. Wysocki has published >100 peer-reviewed articles on translational, clinical, and preclinical cancer research (ORCID ID: 0000-0003-4003-5278). His educational activities involve lectures and online courses for oncologists, residents and medical students (Jagiellonian University, Poznan University of Medicine). His portfolio comprises >1000 lectures and presentations given during national and international meetings, webinars, and symposia over the last 20 years.